Hutch News

Hutch News

Stories tagged 'Cancers'

Fred Hutch collaborates with new Allen Institute for Immunology

Multipartner initiative aims to map the immune system in health and disease

Dec. 12, 2018 | By Sabrina Richards / Fred Hutch News Service

Researchers from Fred Hutchinson Cancer Research Center will partner with the new Allen Institute for Immunology to chart the human immune system by harnessing big data and emerging technologies.

View story >


Exploring why people with HIV have a higher risk of lung cancer

120 volunteers to enroll in Seattle-area study of cancer-related gene mutations

Dec. 4, 2018 | By Sabin Russell / Fred Hutch News Service

Researchers Fred Hutch announced on Dec. 1 the start of a new study with a goal to understand why those who are HIV-positive are at higher risk of lung cancer.

View story >


'Exciting' but early results in trial of immunotherapy for myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease

Dec. 3, 2018 | by Susan Keown / Fred Hutch News Service

The patients were out of options to treat their advanced myelomas. Then, they enrolled on a new clinical trial of genetically reprogrammed immune cells called CAR T cells.

View story >


Study unveils 40 new mutations linked to colorectal cancer

Q&A: Dr. Riki Peters on what this large genome-wide association study means for patients and the public

Dec. 3, 2018 | By Diane Mapes / Fred Hutch News Service

Scientists at 130 institutions, including Fred Hutch, found 40 new inherited mutations linked to colorectal cancer risk. Dr. Riki Peters explains the genome-wide association study's results.

View story >


Dr. Sita Kugel named 2018 V Scholar

Pancreatic cancer researcher will focus on development of targeted therapeutics

Nov. 20, 2018 | By Sabrina Richards / Fred Hutch News Service

Fred Hutchinson Cancer Research Center pancreatic cancer researcher Dr. Sita Kugel has been named a 2018 V Scholar by the V Foundation for Cancer Research. The two-year, $200,000 award will support Kugel’s goal of developing a targeted therapy for an aggressive subtype of pancreatic cancer.

View story >


Study aims to cure blood cancers with transplants that could block HIV, too

10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene

Nov. 16, 2018 | By Sabin Russell / Fred Hutch News Service

Fred Hutch is about to lead a clinical trial offering cord blood transplants to blood cancer patients who also have HIV. The tranplants will carry a genetic trait that naturally confers resistance to HIV, so there is a possibility these transplants might also cure their HIV.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.